FDA OFFICE OF POST-MARKETING DRUG RISK ASSESSMENT WILL TRACK PHASE IV SAFETY STUDIES; TWO DRUG RISK DIVISIONS WILL DIVIDE NME WORKLOAD, TRACK DRUGS IN TEAMS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".